Published On: 2/20/2020
TARGET-IBD Poster & Oral Presentation at ECCO
Earlier this month, TARGET attended the 15th annual Congress of European Crohn’s and Colitis Organisation (ECCO) event in Vienna, Austria. TARGET was selected to present two encores from the 2019 American College of Gastroenterology meeting.
The first was accepted as a poster, “Oral Mesalamine Use in Crohn’s Disease After Implementation of the American College of Gastroenterology Guidelines: A TARGET-IBD Cohort Study”. It was presented by Bruce Sands, MD, a TARGET-IBD steering committee Co-Chair and Chief of the Dr. Henry D. Janowitz Division of Gastroenterology at Mount Sinai.
The second was accepted as a digital oral presentation titled “Medication Use and Comorbidities Among Elderly as Compared to Younger Patients with Inflammatory Bowel Disease in the TARGET-IBD Cohort”. It was also presented by Dr. Sands.
The focus of the talk was on characterizing inflammatory bowel disease-related medications in elderly patients. Notable findings were that mesalamine use was the most common medication among patients over 65 years of age (even for Crohn’s disease patients), and that use of anti-tumor necrosis factor alpha medications decreased in patients in the older age groups when compared to patients under 30 years of age. The presentation was additionally honored as the Best Digital Oral Presentation of Session 3.
You can find all of the presented TARGET-IBD posters on our Publications page.
About Target RWE
As the industry's best-in-class, complete real world evidence (RWE) solution, Target RWE is a distinctly collaborative enterprise that unifies real world data (RWD) sets and advanced RWE analytics in an integrated community, shifting the paradigm in healthcare for how decisions are made to improve lives.
Target RWE sources unique, connected data sets across multiple therapeutic areas representing granular data from diverse patients in academic and community settings. Our rigorous, interactive, and advanced RWE analytics extract deep insights from RWD to answer important questions in healthcare. Target RWE brings together the brightest minds in healthcare through an unmatched community of key opinion leaders, patients, and healthcare stakeholders in a collaborative and dynamic model. www.targetrwe.com
Contact:
Kayla Slake
Marketing Manager
984.234.0268 ext 205
More News
-
12/04/2023
Overcoming Scalability Challenges in Real-World Data Processing for Transformative Patient Care -
11/13/2023
Real-World Evidence in Pharmaceutical Drug Development – Faster, Safer and More Relevant? -
10/23/2023
Leveraging Real-World Evidence with Analytics: 3 Essential Components to Capture a 360-Degree View of Your Patient Population -
11/13/2023
TARGET-NASH Offers Unprecedented Glimpse into Growing Public Health Concerns with Few Treatment Options -
11/10/2023
Target RWE Releases Important Updates on the Cirrhosis Quality Collaborative/TARGET-Liver Disease Partnership with the American Association for the Study of Liver Diseases